Jagsonpal Pharmaceuticals informs about Code of Conduct of Fair Disclosure

08 Jun 2015 Evaluate

Jagsonpal Pharmaceuticals has informed that Pursuant to Regulation 8 & 9 of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation, 2015, the Company has submitted the Code of Practices and procedures for fair disclosure of Unpublished Price Sensitive Information.

The above information is a part of company’s filings submitted to BSE.

Jagsonpal Pharma Share Price

169.70 -4.45 (-2.56%)
09-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.60
Dr. Reddys Lab 1286.40
Cipla 1325.15
Zydus Lifesciences 908.65
Lupin 2301.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×